SCIDOT-16. T2-WEIGHTED IMAGING MAY BE INDICATIVE OF DRUG DISTRIBUTION IN GLIOBLASTOMA PATIENTS

Pamela R. Jackson; Minjee Kim; Andrea Hawkins-Daarud; Kyle W. Singleton; Afroz S. Mohammad; Terence C. Burns; Ian F. Parney; Leland S. Hu; Timothy J. Kaufmann; William F. Elmquist; Jann N. Sarkaria; Kristin R. Swanson

doi:https://doi.org/10.1093/neuonc/noz175.1152

doi.org/10.1093/neuonc/noz175.1152

SCIDOT-16. T2-WEIGHTED IMAGING MAY BE INDICATIVE OF DRUG DISTRIBUTION IN GLIOBLASTOMA PATIENTS

,

,

..., Kristin R. Swanson

42

Neuro-Oncology15.90

Volume: 21, Issue: Supplement_6, Pages: vi274 - vi275

Published: Nov 1, 2019

Abstract

OBJECTIVES Dogma suggests that for brain tumors, regions of enhancement on T1-weighted gadolinium contrast enhanced (T1Gd) magnetic resonance imaging (MRI) correlate with intravenously delivered drug distribution as enhancement indicates a compromised blood-brain barrier (BBB). However, poor response to intravenous therapies highlights the importance of the diffuse disease beyond enhancing regions. This study investigated whether imaging...

Paper Fields

Paper Details

Title

SCIDOT-16. T2-WEIGHTED IMAGING MAY BE INDICATIVE OF DRUG DISTRIBUTION IN GLIOBLASTOMA PATIENTS

DOI

doi.org/10.1093/neuonc/noz175.1152

Published Date

Nov 1, 2019

Journal

Neuro-Oncology

Volume

21

Issue

Supplement_6

Pages

vi274 - vi275

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History